Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03601702
EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke
Sponsor: Niguarda Hospital
View on ClinicalTrials.gov
Summary
The primary aim of Registrap study is to assess the safety and effectiveness of the EmboTrap®II Clot Retriever device (Neuravi) in patients with acute ischemic stroke from large vessel occlusion.
Official title: Multicentric Observational Prospective Study on the Use of the EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2022-01-01
Completion Date
2027-06-15
Last Updated
2026-04-16
Healthy Volunteers
No
Conditions
Interventions
DEVICE
Mechanical thrombectomy with EmboTrap ® II Device
Endovascular treatment with mechanical thrombectomy using EmboTrap ® II Device (Neuravi)
Locations (1)
ASST GOM Niguarda
Milan, Italy